Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented
Generic Name: dry idea advanced dry roll-on antiperspirant and deodorant unscented
Brand Names:
Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented
OTC Purpose
Overview
OTC Purpose
Uses
Indications & Usage
Dosage
Dosage & Administration
Side Effects
OTC-Stop Use Section
Warnings
Warnings
Frequently Asked Questions
What is Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented used for?▼
Indications & Usage
What are the side effects of Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented?▼
OTC-Stop Use Section
What are the important warnings for Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented?▼
Warnings
Related Medications
Red Maple
red maple
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ACER RUBRUM POLLEN (.05 g/mL). Category: BLA.
Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin, Rutinic Acid, Iodium, Capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum, Phytolacca Decandra, Spongia Tosta, Thyroidinum (bovine), Pituitarum Posterium (bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus, Lapis Albus
foeniculum vulgare, ammonium bromatum, fucus vesiculosus, lecithin, rutinic acid, iodium, capsicum annuum, galium aparine, hypothalamus suis, kali bichromicum, lac defloratum, phytolacca decandra, spongia tosta, thyroidinum (bovine), pituitarum posterium (bovine), antimonium crudum, argentum metallicum, calcarea carbonica, adrenalinum, phosphorus, lapis albus
Non-Standardized Plant Allergenic Extract [EPC]
PURPOSE: Appetite suppressant to control empty feeling in stomach otherwise relieved by eating. Helps with metabolic tendencies to gain weight, helps to suppress cravings. Aids in mobilization of fatty tissue, resets the hypothalamus and provides thyroid support.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Tarlatamab-dlle
tarlatamab-dlle
11 DESCRIPTION Tarlatamab-dlle is a bispecific DLL3-directed CD3 T-cell engager that binds to DLL3 expressed on the surface of cells, including tumor cells, and CD3 expressed on the surface of T cells. Tarlatamab-dlle is produced using recombinant DNA technology in Chinese hamster ovary cells. It consists of 982 amino acids and has a molecular weight of approximately 105 kilodaltons.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.